Market open
CryoPort/$CYRX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About CryoPort
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Ticker
$CYRX
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
1,100
Website
CryoPort Metrics
BasicAdvanced
$396M
Market cap
-
P/E ratio
-$3.68
EPS
1.58
Beta
-
Dividend rate
Price and volume
Market cap
$396M
Beta
1.58
52-week high
$20.11
52-week low
$5.32
Average daily volume
369K
Financial strength
Current ratio
8.382
Quick ratio
7.803
Long term debt to equity
96.123
Total debt to equity
101.126
Interest coverage (TTM)
-12.77%
Management effectiveness
Return on assets (TTM)
-4.45%
Return on equity (TTM)
-36.54%
Valuation
Price to revenue (TTM)
1.744
Price to book
0.99
Price to tangible book (TTM)
2.34
Price to free cash flow (TTM)
-8.737
Growth
Revenue change (TTM)
-6.26%
Earnings per share change (TTM)
280.90%
3-year revenue growth (CAGR)
10.11%
3-year earnings per share growth (CAGR)
25.41%
What the Analysts think about CryoPort
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for CryoPort stock.
CryoPort Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
CryoPort Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
CryoPort News
AllArticlesVideos
The Schall Law Firm Is Inquiring Into Potential Securities Law Violations By Cryoport Inc And Asks Investors To Help
Accesswire·3 months ago
The Schall Law Firm Opens Investigation Into Cryoport Inc And Encourages Shareholders To Reach Out
Accesswire·3 months ago
The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Shareholders To Reach Out
Accesswire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CryoPort stock?
CryoPort (CYRX) has a market cap of $396M as of November 08, 2024.
What is the P/E ratio for CryoPort stock?
The price to earnings (P/E) ratio for CryoPort (CYRX) stock is 0 as of November 08, 2024.
Does CryoPort stock pay dividends?
No, CryoPort (CYRX) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next CryoPort dividend payment date?
CryoPort (CYRX) stock does not pay dividends to its shareholders.
What is the beta indicator for CryoPort?
CryoPort (CYRX) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.